(Total Views: 627)
Posted On: 09/30/2020 7:01:19 PM
Post# of 145890
Thanks TechGuru. I agree 56% mortality reduction is a difficult target to hit. And if hit, no way the trial continues to run unless distribution and manufacturing are not ready to deliver product to hospitals.
I suspect that the mortality reduction will be more modest, maybe 20 or 30 percent. Not enough to end the trial. Just my guess.
I suspect that the mortality reduction will be more modest, maybe 20 or 30 percent. Not enough to end the trial. Just my guess.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)